Maryland Zantac expert witnesses bring clinical and scientific insight to cases involving ranitidine use and alleged NDMA exposure. They often come from gastroenterology, oncology, pharmacology, toxicology, and regulatory quality roles within Maryland’s Johns Hopkins Medicine and University of Maryland Medical System networks. They commonly evaluate prescribing standards, product stability, exposure pathways, and causation for cancer-related outcomes.